Daily BriefsECM

Daily Brief ECM: [Japan ECM] Financial Crossholders Offering Isuzu (7202) – Big Buyback Covers Most Of The Back End and more

In today’s briefing:

  • [Japan ECM] Financial Crossholders Offering Isuzu (7202) – Big Buyback Covers Most Of The Back End
  • Isuzu Motors Placement – Relatively Small Deal Along with Buyback
  • Shein IPO: Hong Kong Yes, London No
  • Initial Thoughts on The Pinkfong Company IPO (Creator of the Baby Shark Brand)
  • Xuanzhu Biopharm (轩竹生物科技) Pre-IPO: Reality Checks Against Claims
  • Omada Health (OMDA): Second Virtual Healthcare Provider Ready to Test the IPO Market


[Japan ECM] Financial Crossholders Offering Isuzu (7202) – Big Buyback Covers Most Of The Back End

By Travis Lundy

  • In line with the trend of financial institutions led by non-life insurers selling out of their cross-holdings, today we get an offering of shares held in Isuzu Motors (7202 JP)
  • Today we got an announcement of 29.28mm shares being offered by a dozen financial institutions and a greenshoe for 15% more. At a 10% discount from here it’s ¥57bn/US$400mm.
  • It is 16 days of ADV, which is big, but the company also announced a ¥50bn buyback from Pricing+6 to end of March 2026. That should stabilise things.

Isuzu Motors Placement – Relatively Small Deal Along with Buyback

By Sumeet Singh

  • A group of shareholders aims to raise around US$380m via selling around 4% of Isuzu Motors (7202 JP).
  • Being another cross-shareholding unwind in Japan, it shouldn’t carry much negative connotations, in our view.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

Shein IPO: Hong Kong Yes, London No

By Douglas Kim

  • Shein announced it is planning for an IPO in Hong Kong in 2025. Shein tried to go public in London, but its attempt has essentially failed. 
  • Due to tariff war and ending de minimis for shipments from China and Hong Kong by the U.S. government, the valuation of Shein could decline to less than $50 billion.
  • Now, as long as the valuation is not excessive but reasonable, there could be a decent demand for this IPO of Shein in Hong Kong. 

Initial Thoughts on The Pinkfong Company IPO (Creator of the Baby Shark Brand)

By Douglas Kim

  • In this insight, we provide our initial thoughts on The Pinkfong Company IPO which is expected to be completed in KOSPI in 2H 2025.
  • The Pinkfong Company is the creator of the Baby Shark brand. Its original “Baby Shark Dance” is the most viewed Youtube video ever (15.9 billion views as of May 2025). 
  • The Pinkfong Company’s valuation was more than 1 trillion won in 2021 (Series B investment round). 

Xuanzhu Biopharm (轩竹生物科技) Pre-IPO: Reality Checks Against Claims

By Ke Yan, CFA, FRM

  • Xuanzhu Biopharm, the biotech arm of HK-listed Sihuan Pharma, is seeking to raise at least USD 100m via a Hong Kong listing. The sole sponsor is CICC.
  • In this insight, we look at the company’s core products and key products, including XBP-3571, XZP-3287 and XZP-3621.
  • While there are some interesting reads from its clinical data, we are of the view that its near-commercial products are still lacking the differentiating factors in respective competitive therapeutic areas.

Omada Health (OMDA): Second Virtual Healthcare Provider Ready to Test the IPO Market

By IPO Boutique

  • After the success of Hinge Health, Omada Health is now testing the IPO waters. 
  • Omada Health set terms with the SEC on Thursday morning for its IPO and will offer 7.9mm shares at $18-$20 with a debut date of Friday, June 6th. 
  • The size of the transaction is manageable and the company is backed by major VC players in the industry. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars